A meta-analysis suggests that abiraterone or apalutamide added to androgen deprivation therapy for men with metastatic castration-sensitive prostate cancer offers the best overall survival.
Pace of annual decline in lung cancer mortality increased from 2009-2013 to 2014-2018 for men, women, overall
Pooled relative risk of 0.988 for each increment of one cup of coffee per day revealed in meta-analysis of cohort studies
Mistrust and concerns about masculinity are important factors that influence Black men’s experience during prostate cancer management.
Investigators evaluated a large sample of commercially insured patients with prostate cancer to assess use of tissue-based gene expression testing.
Nubeqa, an androgen receptor inhibitor, was approved for the treatment of patients with nmCRPC based on data from the placebo-controlled phase 3 ARAMIS trial.
Diets that promote hyperinsulinemia and inflammation increase the likelihood of advanced or fatal prostate cancer, a new study suggests.
With the advent of more reliable and accurate ways to screen for prostate cancer, such as PSA testing and prostate MRI, the authors argue that it is time to stop the “antiquated practice” of the digital rectal examination.
In a study of men on active surveillance for localized prostate cancer, each 1-unit increase in Mediterranean diet score, calculated based on patients’ baseline food frequency questionnaire information, was associated with a 12% decreased risk for Gleason grade group progression.
Orgovyx is an oral nonpeptide gonadotropin-releasing hormone (GnRH) receptor antagonist.